Histomorphometric differences between perineural and intraneural application of 0.5% ropivacaine in Wistar rats
DOI:
https://doi.org/10.5457/ams.v50i1-2.534Keywords:
ropivacaine, peripheral nerve blocks, neurotoxicityAbstract
Background: Ropivacaine is a long-acting amide local anaesthetic agent and first produced as a pure enantiomer. Ropivacaine is thought to be one of the safest local anesthetics however, there have been several studies detailing possible neurotoxic effects. At present, the exact molecular mechanism of ropivacaine-mediated neurotoxicity is unknown. We postulated that intraneural injection of 0,5% ropivacaine results in greater nerve injury and this would be proved by objective quantitative histological analysis.
Methods: We used quantitative histomorphometric analyses to evaluate the neurotoxic effect of 0.5% ropivacaine after intraneural and perineural injection of sciatic nerve in Wistar rats. 30 Wistar rats were studied. After general anesthesia, the sciatic nerves (n=60) were exposed bilaterally. Under direct vision, a 27-gauge needle was placed perineurally (n=30) or intraneurally (n=30) and 4 ml of 0.5% ropivacaine was injected using automated pump at speed 3 ml/min. Manometer wes used to measure injection pressure. Three days after application, animals were euthanized and nerves samples were taken for histomorphometric analysis.
Results: All intraneural injections showed significantly smaller number of nerve fibers (p<0,001), smaller nerve fiber (p<0,002) and axon diameter (p<0,001) and myelin thickness (p<0,002) compared with perineurally administarated 0.5% ropivacaine. Maximum achieved injection pressures were 20,3 psi (intraneural) vs 6,7 psi (perineural).
Conclusion: Intraneural injection of 0,5% ropivacaine resulted in an indistiguishable quantitative histologic changes. Intraneural injection is associated with significantly higer injection pressure as compared to the perineural injection. Ropivacaine administered intrafascicularly is neurotoxic, similar to other local anesthetics.
Downloads
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
